Oxford Biomedica Plc (OXB.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -33,338 | 28,793 | -17,876 | 6,891 | -25,893 |
| Other Working Capital | -34,383 | 17,457 | 4,932 | -12,909 | -12,154 |
| Other Operating Activity | 17,055 | -74,767 | 329 | 31,473 | 41,163 |
| Operating Cash Flow | $-50,666 | $-28,517 | $-12,615 | $25,455 | $3,116 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,496 | -1,442 | 43,704 | -9,461 | -13,358 |
| Net Acquisitions | 9,004 | 0 | -99,206 | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | 0 | 2,523 |
| Other Investing Activity | 4,124 | 4,248 | -960 | 0 | 34 |
| Investing Cash Flow | $5,632 | $2,806 | $-56,462 | $-9,461 | $-10,801 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 64,866 | N/A | N/A |
| Debt Repayment | -466 | 0 | -31,424 | N/A | 0 |
| Common Stock Issued | 17,526 | 651 | 80,154 | 51,600 | 41,060 |
| Other Financing Activity | -14,152 | -13,354 | -14,974 | -5,393 | -2,875 |
| Financing Cash Flow | $2,908 | $-12,703 | $98,622 | $46,207 | $38,185 |
| Exchange Rate Effect | -940 | 845 | 2,796 | N/A | N/A |
| Beginning Cash Position | 103,716 | 141,285 | 108,944 | 46,743 | 16,243 |
| End Cash Position | 60,650 | 103,716 | 141,285 | 108,944 | 46,743 |
| Net Cash Flow | $-42,126 | $-38,414 | $29,545 | $62,201 | $30,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,666 | -28,517 | -12,615 | 25,455 | 3,116 |
| Capital Expenditure | -7,496 | -9,832 | -16,296 | -9,461 | -13,358 |
| Free Cash Flow | -58,162 | -38,349 | -28,911 | 15,994 | -10,242 |